Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
暂无分享,去创建一个
P. J. van den Elsen | E. Schooten | Tjadine M Holling | Erik Schooten | Peter J van Den Elsen | T. Holling
[1] H. Weiner,et al. Reciprocal expression of co‐stimulatory molecules, B7‐1 and B7‐2, on murine T cells following activation , 1995, European journal of immunology.
[2] G. Freeman,et al. Early signaling defects in human T cells anergized by T cell presentation of autoantigen , 1992, The Journal of experimental medicine.
[3] K. Bobbitt,et al. Regulation of MHC Class II Signal Transduction by the B Cell Coreceptors CD19 and CD221 , 2000, The Journal of Immunology.
[4] T. Wyss-Coray,et al. T cells as antigen-presenting cells. , 1994, Immunology today.
[5] A. Rudensky,et al. Lysosomal cysteine proteases regulate antigen presentation , 2003, Nature Reviews Immunology.
[6] B. Mach,et al. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA , 1997, The EMBO journal.
[7] R. Lechler,et al. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? , 2003, Blood.
[8] S. Kanner,et al. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells. , 1992, Journal of Immunology.
[9] R. Lechler,et al. Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals. , 1996, Journal of immunology.
[10] C. Thompson,et al. The central effectors of cell death in the immune system. , 1999, Annual review of immunology.
[11] A. Wong,et al. Regulation and Specificity of MHC2TA Promoter Usage in Human Primary T Lymphocytes and Cell Line1 , 2002, The Journal of Immunology.
[12] A. Lokshin,et al. Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II. , 2002, International immunology.
[13] R. Siliciano,et al. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion , 1988, Cell.
[14] E. Satyaraj,et al. Induction of tolerance in freshly isolated alloreactive T cells by activated T cell stimulators is not due to the absence of CD28-B7 interaction. , 1995, Journal of immunology.
[15] P. Cresswell,et al. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. , 1997, Science.
[16] R. Lechler,et al. Antigen presentation by keratinocytes induces tolerance in human T cells , 1990, European journal of immunology.
[17] J. Bluestone,et al. The B7 and CD28 receptor families. , 1994, Immunology today.
[18] I. Cohen,et al. Expression of major histocompatibility complex class II molecules in rat T cells , 1994, European journal of immunology.
[19] T. Yoshino,et al. CD80 (B7-1) and CD86 (B7-2) antigens on house dust mite-specific T cells in atopic disease function through T-T cell interactions. , 1999, The Journal of allergy and clinical immunology.
[20] V. Barnaba,et al. Professional presentation of antigen by activated human T cells , 1994, European journal of immunology.
[21] P. Cresswell,et al. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.
[22] M. Mannie,et al. MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders. , 2001, Cellular immunology.
[23] T. Wyss-Coray,et al. Antigen‐presenting human T cells and antigen‐presenting B cells induce a similar cytokine profile in specific T cell clones , 1993, European journal of immunology.
[24] T. Wyss-Coray,et al. Use of antibody/peptide constructs of direct antigenic peptides to T cells: evidence for T cell processing and presentation. , 1992, Cellular immunology.
[25] R. Winchester,et al. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells , 1979, The Journal of experimental medicine.
[26] R. Doebele,et al. Accessory molecules for MHC class II peptide loading. , 2000, Current opinion in immunology.
[27] D. Sansom,et al. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro , 1993, European journal of immunology.
[28] G. Schieven,et al. HLA-DR molecules enhance signal transduction through the CD3/Ti complex in activated T cells. , 1991, Tissue antigens.
[29] E. Yunis,et al. Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens , 1978, The Journal of experimental medicine.
[30] D. E. Anderson,et al. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. , 1997, Journal of immunology.
[31] Abraham Kupfer,et al. TCR-Induced Transmembrane Signaling by Peptide/MHC Class II Via Associated Ig-α/β Dimers , 2001 .
[32] W. Reith,et al. Deregulated MHC Class II Transactivator Expression Leads to a Strong Th2 Bias in CD4+ T Lymphocytes 1 , 2003, The Journal of Immunology.
[33] J. Roth,et al. Increased MHC class II and CD25 expression on lymphocytes in the absence of persistent lymphocytosis in cattle experimentally infected with bovine leukemia virus. , 1998, Veterinary immunology and immunopathology.
[34] C. Morton,et al. Antiproliferative mechanism of anti-class II monoclonal antibodies. , 1989, Cellular immunology.
[35] H. Mitsuya,et al. Cross-linking HLA-DR molecules on Th1 cells induces anergy in association with increased level of cyclin-dependent kinase inhibitor p27(Kip1). , 2002, Immunology letters.
[36] C. Benoist,et al. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. , 1990, Annual review of immunology.
[37] O. Janssen,et al. Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression. , 1989, Cellular immunology.
[38] A. Langerak,et al. Regulation of MHC class II expression in human T-cell malignancies. , 2004, Blood.
[39] J. Trowsdale,et al. In Vivo and In Vitro Modulation of HLA-DM and HLA-DO Is Induced by B Lymphocyte Activation1 , 2001, The Journal of Immunology.
[40] P. J. van den Elsen,et al. DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies. , 2003, Clinical immunology.
[41] R. Lechler,et al. Anergic T cells act as suppressor cells in vitro and in vivo , 1999, European journal of immunology.
[42] R. Dudek,et al. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes. , 2001, Cellular immunology.
[43] M. Jenkins,et al. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. , 1988, Journal of immunology.
[44] P. J. van den Elsen,et al. Activated Human T Cells Accomplish MHC Class II Expression Through T Cell-Specific Occupation of Class II Transactivator Promoter III1 , 2002, The Journal of Immunology.
[45] J. Freed,et al. Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[46] F. Momburg,et al. HLA-DM, HLA-DO and tapasin: functional similarities and differences. , 2002, Current opinion in immunology.
[47] M. Feldmann,et al. Human T cell clones present antigen. , 1989, Journal of immunology.
[48] A. Singer,et al. Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras. , 1981, Journal of immunology.
[49] M. Loken,et al. I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. , 1982, Journal of immunology.
[50] S. Matsushita,et al. Ligation of HLA-DR Molecules on B Cells Induces Enhanced Expression of IgM Heavy Chain Genes in Association with Syk Activation* , 2000, The Journal of Biological Chemistry.
[51] P. J. van den Elsen,et al. Shared regulatory elements in the promoters of MHC class I and class II genes. , 1998, Immunology today.
[52] D. Hafler,et al. Presentation of autoantigen by human T cells. , 1991, Journal of immunology.
[53] M. Mannie,et al. Acquisition of functional MHC class II/peptide complexes by T cells during thymic development and CNS-directed pathogenesis. , 2002, Cellular immunology.
[54] J. Chi,et al. HLA-DR expression in human fetal thymocytes. , 1992, Human immunology.
[55] J. Trowsdale,et al. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading , 1997, Current Biology.
[56] M. Tesar,et al. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells , 2002, Nature Medicine.
[57] W. van Eden,et al. Anergic T cells actively suppress T cell responses via the antigen‐presenting cell , 1998, European journal of immunology.
[58] D. Charron,et al. MHC class II isotype‐specific signaling complex on human B cells , 2002, European journal of immunology.
[59] A. Lanzavecchia,et al. T cells can present antigens such as HIV gp120 targeted to their own surface molecules , 1988, Nature.
[60] D. Charron,et al. A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytes. , 2002, International immunology.
[61] C. Janeway,et al. CIITA activates the expression of MHC class II genes in mouse T cells. , 1995, International immunology.
[62] G. Schieven,et al. Signal transduction by HLA-DR is mediated by tyrosine kinase(s) and regulated by CD45 in activated T cells. , 1991, Human immunology.
[63] W. van Eden,et al. Antigen presentation by T cells versus professional antigen‐presenting cells (APC): differential consequences for T cell activation and subsequent T cell‐APC interactions , 1999, European journal of immunology.
[64] G. Groenewegen,et al. Canine MHC-class II antigens on B and T lymphocytes. , 2008, Tissue antigens.
[65] J. Monier,et al. Anti-alpha chain monoclonal antibodies of equine MHC class-II antigens: applications to equine infectious anaemia. , 1997, Research in veterinary science.
[66] T. Wyss-Coray,et al. Discrimination of human CD4 T cell clones based on their reactivity with antigen‐presenting T cells , 1992, European journal of immunology.
[67] S. Matsushita,et al. Monocytes Are Differentially Activated Through HLA-DR, -DQ, and -DP Molecules Via Mitogen-Activated Protein Kinases1 , 2001, The Journal of Immunology.
[68] F. Deist,et al. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes. , 1997, Blood.
[69] G. Freeman,et al. The B7–CD28 superfamily , 2002, Nature Reviews Immunology.
[70] L. Racioppi,et al. HLA class II molecules transduce accessory signals affecting the CD3 but not the interleukin-2 activation pathway in T blasts. , 1993, Human immunology.
[71] D. H. Burgess,et al. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. , 1999, Journal of immunology.
[72] R. Lechler,et al. Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells , 1992, The Journal of experimental medicine.
[73] T. Wyss-Coray,et al. The B7 adhesion molecule is expressed on activated human T cells: Functional involvement in T‐T cell interactions , 1993, European journal of immunology.
[74] C. Issel,et al. General method for the detection and in vitro expansion of equine cytolytic T lymphocytes. , 1998, Journal of immunological methods.
[75] E. Choi,et al. Thymocytes positively select thymocytes in human system. , 1997, Human immunology.
[76] L. Lanier,et al. Functional expression of B7/BB1 on activated T lymphocytes , 1993, The Journal of experimental medicine.
[77] W. Reith,et al. The bare lymphocyte syndrome and the regulation of MHC expression. , 2001, Annual review of immunology.
[78] G. Bishop,et al. Signaling Through MHC Class II Molecules Blocks CD95-Induced Apoptosis1 , 2001, The Journal of Immunology.
[79] R. Lechler,et al. Interferon-γ-treated renal tubular epithelial cells induce allospecific tolerance , 1998 .
[80] D. Charron,et al. Lymphocyte programmed cell death is mediated via HLA class II DR. , 1994, International immunology.